Colchicine under consideration by Health Canada as a COVID-19 treatmentQuebec study suggests colchicine may reduce death or hospitalization in outpatients with COVID-19. Foclivia, second H5N1 pandemic influenza vaccine now approved in CanadaVaccine will be made available in the event of an H5N1 influenza pandemic situation. NACI issues second update to COVID-19 vaccine recommendations Clarifies guidance on using vaccine during pregnancy, breastfeeding, and in other special populations, and adds advice concerning dose spacing. Flu facts and myths Cold remedies that help How long is a cold or flu contagious? NACI updates COVID-19 vaccine recommendations to include Moderna vaccine Provides guidance on vaccine dosage schedules and interchangeability, as well as vaccine use in special populations. Favipiravir oral tablets being considered by Health Canada as a COVID-19 treatment Third drug to be filed for treatment of COVID-19 under Interim Order, following IV remdesivir and IV bamlanivimab. Is Pfizer-BioNTech COVID-19 vaccine OK during pregnancy/breastfeeding or if immunocompromised? NACI issues recommendations for use in special populations and addresses other key issues including vaccine efficacy, co-administration with other vaccines, dosing, post-vaccination counselling. What to tell patients about news reports concerning allergic reactions to COVID-19 vaccine Health Canada advises patients to tell healthcare providers about any history of serious allergic reactions before receiving COVID-19 vaccine. First Previous 68 69 70 71 72 Next Last
